A Single-Centre, Open-Label, One-Sequence, Crossover Study to Investigate the Effects of Multiple Doses of Carbamazepine on the Pharmacokinetics of a Single Dose RO4917523 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Basimglurant (Primary) ; Carbamazepine
- Indications Bipolar disorders; Epilepsy; Fragile X syndrome; Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Roche
- 25 Mar 2013 Actual end date (Oct 2012) added as reported by ClinicalTrials.gov.
- 19 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jul 2012 New trial record